The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

Safety of Once daily non XR Viramune

Nov 25, 2012

Hello doctor, I'm currently on Twice daily Viramune+ Truvada for 1 month, previously I was on Atripla for 5 months. I'm currently UD CD4 520 26% MY liver function is: AST 22, ALT 21. My Question is; I read about once daily dosing for non-XR Nevirapine, I would like to ask about safety and efficacy of once daily dosing. Is it safe to switch?

Unfortunately, Nevirapine XR is still not available where I live.

Response from Dr. Young

Hello and thanks for posting.

While the generic version of nevirapine isn't formally approved for once-daily dosing, it is commonly prescribed this way. Additionally, switching to nevirapine from a successful regimen doesn't seem to bear the same risks for liver toxicity as when starting first-line therapy with high CD4 cell counts.

So, in sum, since you're already doing well on twice-daily nevirapine, it should be fine to take all of your medications (including the now 2 pills of nevirapine) once-daily.

Hope that helps, and let our readers know how this works for you. BY

Efavirenz danger?
interaction between crack cocaine and kaletra, trizivir

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint